Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes Hydes TJ, Summers N, Brown E, et al. Diabet Med. 2020 Jul 3. http://doi.org/10.1111/dme.14356
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial Perkovic V.; Toto R, Cooper ME. et al. Diabetes Care. 2020 Aug; 43(8): 1803–1812. http://doi.org/10.2337/dc20-0279